Infor Reports Q1 License Revenue at Double-Digit Growth NEW

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
Infor Reports Q1 License Revenue at Double-Digit Growth

NEW YORK, NY --(Marketwired - September 16, 2014) - Infor , a leading provider of business application software serving more than 73,000 customers, announced on its quarterly Lender Update Friday, September 12, that fiscal 2015 Q1 software license fees and subscriptions revenue increased 22 percent at actual currency rates and in constant currency 1 compared to its fiscal 2014 recast Q1. Non-GAAP Q1 license fees and subscriptions revenue 2 increased 21 percent at actual currency rates and 20 percent in constant currency driven by strong license sales and continued momentum in software-as-a-service (SaaS) in the first quarter of Infor's fiscal year 2015. The areas of performance that showed the most momentum were the result of the continued drumbeat of Infor 10x product releases including Infor CloudSuite™ , which was announced in March of this year.

Bookings of SaaS subscription licenses more than doubled from the same quarter in FY14. This marked the first full quarter of sales for Infor CloudSuite, the first group of industry-specific application suites available on Amazon Web Services' (AWS) cloud. Since its announcement in March, Infor has delivered CloudSuites for Automotive , Aerospace & Defense , Hospitality , and Industrial Manufacturing . Infor now has more than 25 million users of its cloud applications.

This week at Inforum, its annual user conference with more than 7,000 registered attendees, Infor will unveil Infor CloudSuite Healthcare, a particularly important industry for Infor, whose products automate approximately 90 percent of the 25 largest U.S. healthcare delivery networks, and Infor CloudSuite Business, a general business management solution for midsize companies.

"The last three-and-a-half-years have truly marked the rebirth of Infor. We've evolved our product suite at an unprecedented pace and spent more than a billion dollars on engineering to deliver beautiful software, purpose-built by industry, on a modern platform," said Charles Phillips, CEO of Infor. "The strong results of our first quarter are only the beginning, over the next 12 months Infor will deliver a step-change in business software with our next enterprise release, Infor Xi, which is built for the cloud, using mobile-first design, and engineered with science to embrace machine-learning and big data analytics for midsize companies to multinational enterprises."

Infor's vertical approach, delivering industry-specific software that significantly reduces costly customization through built-in feature-rich functionality, continues to contribute to strong growth. In this quarter, Infor experienced double-digit growth in many of its primary business units, including Public Sector, Healthcare, Human Capital Management, CRM, and Financial Management.

Keep Current on Infor:

About Infor Infor is fundamentally changing the way information is published and consumed in the enterprise, helping 73,000 customers in more than 200 countries and territories improve operations, drive growth, and quickly adapt to changes in business demands. Infor offers deep industry-specific applications and suites, engineered for speed, and with an innovative user experience design that is simple, transparent, and elegant. Infor provides flexible deployment options that give customers a choice to run their businesses in the cloud, on-premises, or both. To learn more about Infor, please visit www.infor.com .

Infor customers include:

  • 19 of the top 20 aerospace companies
  • 10 of the top 10 high tech companies
  • 10 of the top 10 pharmaceutical companies
  • 22 of the 25 largest U.S. healthcare delivery networks
  • 16 of the 20 largest US cities 
  • 20 of the top 20 automotive suppliers
  • 17 of the top 20 industrial distributors
  • 16 of the top 20 global retailers
  • 4 of the top 5 brewers

Forward-Looking Statements This press release contains forward-looking statements that state Infor's intentions, beliefs, expectations, or predictions for the future. Forward-looking statements often include use of the future tense with words such as "will," "may," "intends," "anticipates," "expects" and similar conditional or forward-looking words and phrases. These forward-looking statements are neither promises nor guarantees, but are only predictions and may differ materially from actual future events or results. Such statements are subject to risks and uncertainties that may cause actual results to differ materially from those in the forward-looking statements. Infor undertakes no obligation to update or revise the information contained herein. 

Important factors that could cause a material difference between these forward-looking statements and actual events include, among other things: our ability to increase revenues from new license sales and retain existing customers; whether we are able to complete and deliver products and services within required time frames and budgets to meet increasingly competitive customer demands and performance guaranties; risks inherent in fluctuating international currency exchange rates in light of our global operations and the unpredictable effect of geopolitical world and local events; our ability to manage expenses effectively and maintain profitability; our ability to achieve revenue from products and services that are under development; the competitive environment in which we operate and resulting pricing pressures; and whether the anticipated effects and results of our new product offerings and successful product implementation will be realized. These and other potential risks and uncertainties that relate to Infor and its business and operations are summarized in more detail from time to time in our filings with the United States Securities and Exchange Commission. Please refer to Infor's most recent quarterly and annual reports available through the website maintained by the SEC at www.sec.gov for more information on the risk factors that could cause actual results to differ.

Footnotes:

1 In order to provide a framework for assessing how our underlying businesses performed excluding the effect of foreign currency fluctuations, we compare the percent change in the results from one period to another period using constant currency disclosure. To present this information, results for our entities in the first quarter of fiscal 2015 reporting in currencies other than the U.S. Dollar are converted into U.S. Dollars at constant exchange rates (i.e. the rates in effect in the recast first quarter of fiscal 2014) rather than the actual exchange rates in effect during the first quarter of fiscal 2015.

2 This press release contains certain financial information determined by methods other than in accordance with generally accepted accounting principles in the United States (GAAP). Non-GAAP software license fees and subscriptions revenues include pro forma adjustments to increase software license fees and subscriptions revenues that we would have recognized if we had not adjusted acquired deferred revenues to their fair values as required by GAAP. These non-GAAP disclosures have limitations as an analytical tool and should not be considered in isolation or as a substitute for analysis of Infor's results as reported under GAAP, nor are they necessarily comparable to non-GAAP performance measures that may be presented by other companies. Infor's management uses these non-GAAP measures in its analysis of Infor's performance because it believes these measures are material and will be used as a measure of Infor's performance by investors.

For more information: Dan Barnhardt  Infor  646-336-1731  dan.barnhardt@infor.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Wally Disrupts Dental Industry with $25M Funding

Updated Category News Views 8

A New Breath of Fresh Air for Dental Care Dental visits—a tedious, costly affair we've all dreaded. So, when Wally rolls out an overhaul in this stale landscape, it's worth taking notice. With $25 million in their pockets from Series A funding led by Maveron, Wally's swaggering in with a plan to flip the script on dental care across the nation. Redefining the Dental...

Continue Reading
Vitamin Angels Drives Global Nutrition Advancements

Updated Category News Views 8

Navigating the Waters of Global Nutrition Bet you never thought a vitamin program could spearhead the front lines of healthcare, huh? Vitamin Angels are grinding away under the radar, shifting the landscape for maternal and child nutrition. At the heart of it all is their vision to make UNIMMAP multiple micronutrient supplementation (MMS) a staple in the global playbook....

Continue Reading
EMCO's New Automated Facility Could Shake Industry

Updated Category News Views 8

A Novel Leap in Production Capacity EMCO Industries just put a solid foot on the accelerator with their brand-new, shiny, fully automated plant over in Claremore, Oklahoma. If you're glancing at heavy-duty trailer springs, you can't ignore the fact that this is a multimillion-dollar investment. Heck, this monstrous 30,000-square-foot facility more than doubles what EMCO...

Continue Reading
OCI N.V. Secures a Win in Court; EGM Proceeds as Planned

Updated Category News Views 11

OCI Dodges a Bullet in Amsterdam Court Stepping into the courtroom drama, OCI N.V. just took home a win as the Amsterdam Court of Appeal's Enterprise Chamber gave them a clean bill of health, kicking out the inquiry request from VEB and a bunch of other shareholders. The judges weren't convinced there was anything fishy going on, so they tossed the inquiry petition and...

Continue Reading
Duke Energy's Cost-Protection Plan Shields Ratepayers

Updated Category News Views 6

Shielding Customers From Data Center Costs Let's get right into the thick of it: Duke Energy's latest move is a strategic one, shrouded in industry terms but with a real impact on regular folks' wallets. The company's agreement with heavyweights like Amazon, Google, and Meta aims to protect existing customers in North Carolina from getting hit with the costs of powering...

Continue Reading
HelloNation Brings 'Edvertising' to NC REALTORS® Event

Updated Category News Views 8

HelloNation's Bold Step into Real Estate Networking October 8th to the 11th is shaping up to be a pivotal few days in Wilmington, North Carolina. Here’s the scoop: HelloNation, known for its innovative 'edvertising' model, is joining the bustling crowd at the 2026 NC REALTORS® Convention. This isn’t just any get-together—it's the grandest annual jamboree for real...

Continue Reading
Ornellaia's 2026 Harvest: Adapting to Nature's Whims

Updated Category News Views 7

A Year Marked by Weather's Unpredictable Dance Nobody said making wine was a walk in the park, and the folks at Ornellaia know better than most how to roll with whatever nature throws their way. The 2026 harvest story is as much about unlocking the secrets of the soil as it is about navigating the quirks of the weather. Situated in Bolgheri, Italy, this year's vintage...

Continue Reading
Merit Expands in New York with Bold Acquisition Move

Updated Category News Views 6

Merit Financial's Growth Trajectory Takes a Leap You watch the movers and shakers in this game long enough, and you start to see patterns. Merit Financial Advisors is one of those juggernauts you'd better keep an eye on. These folks just scooped up Moldenhauer & Associates—a firm that's been a staple in Orchard Park, New York—for a cool $1.1 billion worth of client...

Continue Reading
Decoding CarBravo-Certified vs Traditional Used Cars

Updated Category News Views 6

What’s Behind Door Number One: CarBravo Certification When you walk onto a car lot these days, it's a mixed bag: shiny badges boasting certifications or basic used car signage. For anyone who's spent time around cars, two types stick out—there’s your CarBravo-certified vehicles and your good ol' used cars. Now, Marissa McCoy and Jill Maniaci from Heidebreicht...

Continue Reading
Gong, Agentforce, Avoma Crowned 2026 CI Champions

Updated Category News Views 6

Diving Deep into Conversation Intelligence There's a lot to unpack when three software titans hog the spotlight, and that's exactly what's happening in the world of conversation intelligence this year. It's like we've hit the jackpot with Gong, Agentforce Sales, and Avoma carving out their turf as the 2026 Champions, according to the venerable Info-Tech Research Group....

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring MARA Holdings: What Investors Need to Know

Updated Category News Views 123

Understanding Short Interest in MARA Holdings MARA Holdings's short percent of float has recently fallen by 5.93%. The company reported 84.21 million shares sold short, which makes up 31.41% of all shares available for trading. With regards to its trading volume, it’s estimated that it would take approximately 1.69 days for traders to cover their short positions on...

Continue Reading
BioLab Holdings, Inc. Unveils Advanced Amniotic Skin Substitute

Updated Category News Views 294

BioLab Holdings, Inc. Unveils Advanced Amniotic Skin Substitute Tri-Membrane Wrap Developed to Protect Deep Wounds in Difficult-to-Cover Areas BioLab Holdings, Inc.'s skin substitute brand, BioLab Sciences, has just introduced an innovative amniotic membrane tissue product called the Tri-Membrane Wrap. This product is specifically designed to enhance wound healing...

Continue Reading
Franklin Resources Faces Challenges Amid Leadership Shakeup

Updated Category News Views 255

Challenges for Franklin Resources Amid Leadership Changes Franklin Resources, Inc. (BEN) is facing significant difficulties due to recent scrutiny and adjustments within its leadership. These challenges follow the company's announcement to close its Macro Opportunities strategy, which managed around $2 billion in assets. Overview of Recent Issues The troubles began on...

Continue Reading
Zentalis Pharmaceuticals Shares Promising Data on Ovarian Cancer Treatment

Updated Category News Views 347

Zentalis Pharmaceuticals Shares Updated Data on Azenosertib Zentalis Pharmaceuticals, Inc. is making significant strides with its innovative treatment, azenosertib, in the fight against platinum-resistant ovarian cancer (PROC). Recent data presented at a major oncology meeting revealed compelling results that highlight the potential of this therapy in improving patient...

Continue Reading
Evercore ISI Adjusts Outlook on Google Amid Legal Challenges

Updated Category News Views 94

Evercore ISI's Updated View on Google Shares Evercore ISI has recently adjusted its perspective on Google (NASDAQ: GOOGL) shares. This shift comes as the Department of Justice (DOJ) prepares for trials that will scrutinize Google's search practices. During a recent webinar hosted by Evercore, prominent legal experts Harry First, a law professor at NYU, and Jennifer Rie, a...

Continue Reading